HALO logo
halo search icon
Appili Therapeutics Inc Class A
Appili Therapeutics Inc Class A
APLI · TSE

Appili Therapeutics Inc Class A

CA$0.015

0.00 (0.00%)
19/05/2026 12:00:00 AM
All-CompaniesHALO AllNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Appili Therapeutics Inc Class A Overview

APLI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About APLI

icon

Telephone

1.902.442.4655

icon

Address

Suite 21, 1344 Summer Street, Halifax, NS B3H 0A8

Description

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.

APLI Price Chart

Key Stats

Market Cap

CA$1.93M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.04

Trade Value (12mth)

US$503.00

1 week

0%

1 month

-25%

YTD

-25%

1 year

0%

All time high

1.89

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

0.00%

Operating Cashflow

N/A

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

128m

HALO Sector

Healthcare

Next Company Report Date

01-Jul-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

APLI Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.03-0.02N/Alocklocklock
EPS (Fully Diluted)
$locklocklocklock-0.03-0.02N/Alocklocklock
Growth
%locklocklocklock61.630.8N/Alocklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The current share price of Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.01.
What is the 52-week high share price for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The 52-week high share price for Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.04.
What is the 52-week low share price for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
The 52-week low share price for Appili Therapeutics Inc Class A (APLI:TSE) is CAD$0.01.
What is the dividend yield for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) does not pay a dividend.
What was Appili Therapeutics Inc Class A (APLI:TSE) last dividend payment?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) does not pay a dividend.
What is the franking level for Appili Therapeutics Inc Class A (APLI:TSE)?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) has a franking level of 0.00%.
In which sector is Appili Therapeutics Inc Class A (APLI:TSE) classified?
Halo FAQ
Appili Therapeutics Inc Class A (APLI:TSE) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.